Cargando…
Correction: GW8510 Increases Insulin Expression in Pancreatic Alpha Cells through Activation of p53 Transcriptional Activity
Autores principales: | Fomina-Yadlin, Dina, Kubicek, Stefan, Vetere, Amedeo, Hu He, Kai Hui, Schreiber, Stuart L., Wagner, Bridget K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297644/ http://dx.doi.org/10.1371/annotation/c41ac082-32ac-4837-b4ed-9fd8ad91c1e0 |
Ejemplares similares
-
GW8510 Increases Insulin Expression in Pancreatic Alpha Cells through Activation of p53 Transcriptional Activity
por: Fomina-Yadlin, Dina, et al.
Publicado: (2012) -
Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
por: Choudhary, Amit, et al.
Publicado: (2014) -
Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
por: Hsieh, Y-Y, et al.
Publicado: (2016) -
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
por: Maianti, Juan Pablo, et al.
Publicado: (2019) -
GW Stewart
por: Kilmer, Misha E, et al.
Publicado: (2010)